Last reviewed · How we verify
NCT04165551
Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
Phase 1 trial testing Probiotic in Streptococcus Agalactiae in 60 participants. Status unknown.
1 September 2020
Quick facts
| Lead sponsor | Biosearch S.A. |
|---|---|
| Phase | Phase 1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 October 2019 |
| Primary completion | 1 September 2020 |
| Estimated completion | 10 September 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Probiotic
- Placebo
Conditions studied
- Streptococcus Agalactiae — all drugs for Streptococcus Agalactiae →
Sponsor
Biosearch S.A. — full company profile →
Who can join
Adults 18 to 45, female only, with Streptococcus Agalactiae. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the effects of oral administration of Lactobacillus BSL\_PS71 on the presence of S. agalactiae in vaginal microbiota of healthy women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04165551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic
Trials testing the same drug.
- NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
- NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
- NCT07462481 — Probiotic Improve Constipation · NA · recruiting
- NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
- NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting
Other Biosearch S.A. trials
Trials by the same sponsor.
- NCT06650670 — Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy Adults · NA · terminated
- NCT06651424 — Effect of Consuming a Combination of Probiotic Strains on Postpartum Depression · NA · terminated
- NCT06254040 — Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment · NA · completed
- NCT04639544 — Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis · NA · unknown
- NCT04639232 — Effect of Consuming a Combination of Probiotic Strains and a Combination of Plant Extracts and a Probiotic Strain on the · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04165551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biosearch S.A.
- Last refreshed: 13 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04165551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing